Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Bayer Aktienges ADR
(OP:
BAYRY
)
7.930
UNCHANGED
Streaming Delayed Price
Updated: 3:59 PM EDT, Oct 22, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
7.930
Bid (Size)
N/A (0)
Ask (Size)
N/A (0)
Prev. Close
7.930
Today's Range
7.930 - 7.930
52wk Range
4.790 - 8.700
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Top 3 Health Care Stocks You'll Regret Missing In October
October 21, 2025
Via
Benzinga
Late-breaking data from Phase III OCEANIC-STROKE study accepted for presentation at World Stroke Congress 2025
October 21, 2025
From
Bayer
Via
Business Wire
Performance
YTD
+60.5%
+60.5%
1 Month
-1.5%
-1.5%
3 Month
-6.6%
-6.6%
6 Month
+26.9%
+26.9%
1 Year
+13.0%
+13.0%
More News
Read More
Exelixis Stock Falls After Phase 3 Colorectal Cancer Trial Shows Mixed Results
October 20, 2025
Via
Benzinga
Bayer Partners with Cornfed Farms to Create First ForwardFarm in Midwest
October 07, 2025
From
Bayer
Via
Business Wire
One A Day® Unveils Bold New Brand Identity and Platform: “The ONE for you”
October 07, 2025
From
Bayer
Via
Business Wire
BlueRock Therapeutics reports positive 36-month results from Phase I trial of bemdaneprocel for treating Parkinson’s disease
October 07, 2025
From
Bayer
Via
Business Wire
Bayer Selects Interpublic as Global Media, Production and Creative Agency Partner for Consumer Health Division
September 29, 2025
From
Bayer
Via
Business Wire
Bayer to Highlight New Data for KERENDIA® (finerenone) at Heart Failure Society of America (HFSA) Annual Scientific Meeting 2025
September 25, 2025
From
Bayer
Via
Business Wire
Bayer First Company to Advance Cell Therapy as Well as Gene Therapy Against Parkinson’s Disease
September 22, 2025
From
Bayer
Via
Business Wire
10 Years of Supporting Rural America: Bayer and Luke Bryan Team Up with Feeding America® to Tackle Hunger with “Take Care, Now” Campaign
September 15, 2025
From
Bayer
Via
Business Wire
Agri-Science Giant Corteva Eyes Breakup To Shield Seed Unit From Future Risks: Report
September 15, 2025
Via
Benzinga
Gadoquatrane New Drug Application Accepted for Review by U.S. FDA
August 27, 2025
From
Bayer
Via
Business Wire
Monsanto Reaches Agreements in Principle to Resolve Additional PCB Cases at the Sky Valley Education Center
August 18, 2025
From
Bayer
Via
Business Wire
Bayer® Aspirin Introduces Aspirina to the U.S. Pain Market
August 15, 2025
From
Bayer
Via
Business Wire
Retail Turns Bearish On Bayer After $1.3B Kumquat Cancer Drug Deal
August 12, 2025
Via
Stocktwits
OTC Markets Group Announces Quarterly Index Performance and Rebalancing
August 04, 2025
From
OTC Markets
Via
GlobeNewswire
U.S. Current-Account Deficit Widens to $450 Billion Amid Trade Imbalances and Energy Imports
July 25, 2025
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Supply Chain
History of Recursion Pharmaceuticals, Inc.: AI‑Driven Drug Discovery Beginnings (NASDAQ:RXRX)
July 21, 2025
Via
MarketMinute
Topics
Artificial Intelligence
Exelixis' Zanzalintinib Combo Boosts Survival In Colorectal Cancer, Stock Soars
June 23, 2025
Via
Benzinga
Exelixis Catapults 14% On Positive Results For Next-Gen Colon Cancer Drug
June 23, 2025
Via
Investor's Business Daily
OTC Markets Group Welcomes Bayer AG to OTCQX
May 23, 2025
From
OTC Markets
Via
GlobeNewswire
Bayer Profit Drops 35%, Launches Overhaul To Counter Generic Pressure
May 13, 2025
Via
Benzinga
FDA Grants Complete Approval To Bayer's Drug For Certain Type Cancer With Mutation
April 10, 2025
Via
Benzinga
Bayer Enters License Agreement With China’s Puhe BioPharma For Cancer Drug Candidate: Retail Stays Bullish
March 26, 2025
Via
Stocktwits
Bayer CEO: 2025 Will Be 'Most Difficult' Year In Turnaround Plan, Expects Improved Performance From 2026 Onwards
March 05, 2025
Via
Benzinga
Topics
Earnings
Frequently Asked Questions
Is Bayer Aktienges ADR publicly traded?
Yes, Bayer Aktienges ADR is publicly traded.
What exchange does Bayer Aktienges ADR trade on?
Bayer Aktienges ADR trades on the OTC Traded
What is the ticker symbol for Bayer Aktienges ADR?
The ticker symbol for Bayer Aktienges ADR is BAYRY on the OTC Traded
What is the current price of Bayer Aktienges ADR?
The current price of Bayer Aktienges ADR is 7.930
When was Bayer Aktienges ADR last traded?
The last trade of Bayer Aktienges ADR was at 10/22/25 03:59 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today